David López

753 total citations
19 papers, 532 citations indexed

About

David López is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Molecular Biology. According to data from OpenAlex, David López has authored 19 papers receiving a total of 532 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 5 papers in Epidemiology and 4 papers in Molecular Biology. Recurrent topics in David López's work include Pulmonary Hypertension Research and Treatments (6 papers), Congenital heart defects research (3 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers). David López is often cited by papers focused on Pulmonary Hypertension Research and Treatments (6 papers), Congenital heart defects research (3 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers). David López collaborates with scholars based in United States, Spain and India. David López's co-authors include David N. Silvers, Elson B. Helwig, Valentı́n Sans-Coma, Kathy Liu, Li Li, Bruno Marchand, Bryan C. Fuchs, David Hollenback, Dmytro Kornyeyev and David G. Breckenridge and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Cancer and Journal of Neurochemistry.

In The Last Decade

David López

15 papers receiving 515 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David López United States 9 271 140 135 128 88 19 532
Maja Walier Germany 9 191 0.7× 115 0.8× 183 1.4× 214 1.7× 89 1.0× 15 783
Kunio Uematsu Japan 13 151 0.6× 71 0.5× 273 2.0× 93 0.7× 108 1.2× 43 598
Claire Coire Canada 13 91 0.3× 40 0.3× 140 1.0× 58 0.5× 48 0.5× 18 415
Yoshinori Urano Japan 11 206 0.8× 39 0.3× 208 1.5× 99 0.8× 147 1.7× 22 595
Hidefumi Inaba Japan 17 282 1.0× 135 1.0× 111 0.8× 109 0.9× 66 0.8× 64 859
Toshiaki Sano Japan 12 92 0.3× 182 1.3× 127 0.9× 66 0.5× 129 1.5× 16 518
Eiichiro Hirakawa Japan 13 74 0.3× 37 0.3× 145 1.1× 108 0.8× 76 0.9× 53 408
Mohammad Alimohammadi Sweden 14 70 0.3× 179 1.3× 55 0.4× 99 0.8× 49 0.6× 21 613
Sladjana Andrejević Serbia 15 83 0.3× 48 0.3× 41 0.3× 89 0.7× 171 1.9× 40 618
Motoaki Chin Japan 16 43 0.2× 99 0.7× 49 0.4× 218 1.7× 99 1.1× 43 540

Countries citing papers authored by David López

Since Specialization
Citations

This map shows the geographic impact of David López's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David López with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David López more than expected).

Fields of papers citing papers by David López

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David López. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David López. The network helps show where David López may publish in the future.

Co-authorship network of co-authors of David López

This figure shows the co-authorship network connecting the top 25 collaborators of David López. A scholar is included among the top collaborators of David López based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David López. David López is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Bartolome, Sonja, et al.. (2025). Qualitative Interviews of Physicians Managing Patients With Methamphetamine-associated Pulmonary Arterial Hypertension: Understanding the Unmet Medical Need From a Provider Lens. American Journal of Respiratory and Critical Care Medicine. 211(Supplement_1). A1422–A1422.
2.
3.
Bellmunt, Joaquim, Júlia Perera‐Bel, Gardenia Vargas‐Parra, et al.. (2025). Prognostic Value of PARP1 and PARP2 Copy Number Alterations in Prostate Cancer. Laboratory Investigation. 105(6). 104171–104171.
4.
Rahhali, Nora, Assunta Senatore, David López, et al.. (2025). A Systematic Literature Review Exploring the Efficacy and Safety of Tadalafil and Sildenafil in Pulmonary Arterial Hypertension. Pulmonary Circulation. 15(4). e70212–e70212.
5.
Elwing, Jean, et al.. (2025). Patient Perspectives on Fixed Dose Combination Therapy for Pulmonary Arterial Hypertension: Exploratory Focus Group Research. Pulmonary Circulation. 15(2). e70098–e70098. 1 indexed citations
6.
Wang, Ting, Christopher W. Pohlmeyer, David López, et al.. (2024). Immune complexes-mediated activation of neutrophils in systemic lupus erythematosus is dependent on RNA recognition by toll-like receptor 8. Frontiers in Immunology. 15. 1515469–1515469. 2 indexed citations
7.
Menéndez, Sílvia, David López, Beatríz Bellosillo, et al.. (2023). Characterization and spatial distribution of the immune cell infiltrate in triple-negative breast cancer: a novel classification based on plasma cells and CD8+ T cells. Human Pathology. 139. 91–105. 5 indexed citations
8.
Juanpere, Núria, Marta Lorenzo, David López, et al.. (2023). Immunohistochemical markers as predictors of prognosis in multifocal prostate cancer. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 485(2). 281–290. 2 indexed citations
9.
Pohlmeyer, Christopher W., Ching Shang, Zhi-Hua Cui, et al.. (2021). Characterization of the mechanism of action of lanraplenib, a novel spleen tyrosine kinase inhibitor, in models of lupus nephritis. BMC Rheumatology. 5(1). 15–15. 10 indexed citations
10.
López, David, et al.. (2020). Releasing the brakes: a case report of pulmonary arterial hypertension induced by immune checkpoint inhibitor therapy. Pulmonary Circulation. 10(4). 1–4. 13 indexed citations
11.
Espíndola, Milena S., David M. Habiel, Ana Lúcia Coelho, et al.. (2020). Differential Responses to Targeting Matrix Metalloproteinase 9 in Idiopathic Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine. 203(4). 458–470. 38 indexed citations
12.
Bates, Jamie, Archana Vijayakumar, Sarani Ghoshal, et al.. (2020). Acetyl-CoA carboxylase inhibition disrupts metabolic reprogramming during hepatic stellate cell activation. Journal of Hepatology. 73(4). 896–905. 154 indexed citations
13.
Arias, Jesús Eduardo Rojo, Matina Economopoulou, David López, et al.. (2019). VEGF‐Trap is a potent modulator of vasoregenerative responses and protects dopaminergic amacrine network integrity in degenerative ischemic neovascular retinopathy. Journal of Neurochemistry. 153(3). 390–412. 11 indexed citations
14.
Davis, Hannah M., Mohammad W. Aref, Alexandra Aguilar‐Perez, et al.. (2018). Cx43 Overexpression in Osteocytes Prevents Osteocyte Apoptosis and Preserves Cortical Bone Quality in Aging Mice. JBMR Plus. 2(4). 206–216. 45 indexed citations
15.
López, David, et al.. (2003). Formation of cartilage in the heart of the Spanish terrapin, Mauremys leprosa (Reptilia, Chelonia). Journal of Morphology. 258(1). 97–105. 23 indexed citations
16.
Fernández, Borja, et al.. (1998). Anatomy and formation of congenital bicuspid and quadricuspid pulmonary valves in Syrian hamsters. The Anatomical Record. 250(1). 70–79. 30 indexed citations
17.
Fernández, Borja, M. Carmen Fernández‐Santaella, Ana C. Durán, et al.. (1998). Anatomy and formation of congenital bicuspid and quadricuspid pulmonary valves in Syrian hamsters. The Anatomical Record. 250(1). 70–79. 2 indexed citations
18.
López, David, David N. Silvers, & Elson B. Helwig. (1975). Ectopic meningiomas of the skin. Archives of Dermatology. 111(12). 1664. 1 indexed citations
19.
López, David, David N. Silvers, & Elson B. Helwig. (1974). Cutaneous meningiomas—a clinicopathologic study. Cancer. 34(3). 728–744. 195 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maja Walier Breakdown of academic impact, for papers by Kunio Uematsu Breakdown of academic impact, for papers by Claire Coire Breakdown of academic impact, for papers by Yoshinori Urano Breakdown of academic impact, for papers by Hidefumi Inaba Breakdown of academic impact, for papers by Toshiaki Sano Breakdown of academic impact, for papers by Eiichiro Hirakawa Breakdown of academic impact, for papers by Mohammad Alimohammadi Breakdown of academic impact, for papers by Sladjana Andrejević Breakdown of academic impact, for papers by Motoaki Chin
Rankless by CCL
2026